Ketamine Use in the Intubation of Critically Ill Children with Neurological Indications: A Multicenter Retrospective Analysis.
Adverse events
Child
Critical illness
Endotracheal intubation
Ketamine
Neurology
Traumatic brain injury
Journal
Neurocritical care
ISSN: 1556-0961
Titre abrégé: Neurocrit Care
Pays: United States
ID NLM: 101156086
Informations de publication
Date de publication:
09 May 2023
09 May 2023
Historique:
received:
19
10
2022
accepted:
10
04
2023
medline:
10
5
2023
pubmed:
10
5
2023
entrez:
10
5
2023
Statut:
aheadofprint
Résumé
Ketamine has traditionally been avoided for tracheal intubations (TIs) in patients with acute neurological conditions. We evaluate its current usage pattern in these patients and any associated adverse events. We conducted a retrospective observational cohort study of critically ill children undergoing TI for neurological indications in 53 international pediatric intensive care units and emergency departments. We screened all intubations from 2014 to 2020 entered into the multicenter National Emergency Airway Registry for Children (NEAR4KIDS) registry database. Patients were included if they were under the age of 18 years and underwent TI for a primary neurological indication. Usage patterns and reported periprocedural composite adverse outcomes (hypoxemia < 80%, hypotension/hypertension, cardiac arrest, and dysrhythmia) were noted. Of 21,562 TIs, 2,073 (9.6%) were performed for a primary neurological indication, including 190 for traumatic brain injury/trauma. Patients received ketamine in 495 TIs (23.9%), which increased from 10% in 2014 to 41% in 2020 (p < 0.001). Ketamine use was associated with a coindication of respiratory failure, difficult airway history, and use of vagolytic agents, apneic oxygenation, and video laryngoscopy. Composite adverse outcomes were reported in 289 (13.9%) Tis and were more common in the ketamine group (17.0% vs. 13.0%, p = 0.026). After adjusting for location, patient age and codiagnoses, the presence of respiratory failure and shock, difficult airway history, provider demographics, intubating device, and the use of apneic oxygenation, vagolytic agents, and neuromuscular blockade, ketamine use was not significantly associated with increased composite adverse outcomes (adjusted odds ratio 1.34, 95% confidence interval CI 0.99-1.81, p = 0.057). This paucity of association remained even when only neurotrauma intubations were considered (10.6% vs. 7.7%, p = 0.528). This retrospective cohort study did not demonstrate an association between procedural ketamine use and increased risk of peri-intubation hypoxemia and hemodynamic instability in patients intubated for neurological indications.
Sections du résumé
BACKGROUND
BACKGROUND
Ketamine has traditionally been avoided for tracheal intubations (TIs) in patients with acute neurological conditions. We evaluate its current usage pattern in these patients and any associated adverse events.
METHODS
METHODS
We conducted a retrospective observational cohort study of critically ill children undergoing TI for neurological indications in 53 international pediatric intensive care units and emergency departments. We screened all intubations from 2014 to 2020 entered into the multicenter National Emergency Airway Registry for Children (NEAR4KIDS) registry database. Patients were included if they were under the age of 18 years and underwent TI for a primary neurological indication. Usage patterns and reported periprocedural composite adverse outcomes (hypoxemia < 80%, hypotension/hypertension, cardiac arrest, and dysrhythmia) were noted.
RESULTS
RESULTS
Of 21,562 TIs, 2,073 (9.6%) were performed for a primary neurological indication, including 190 for traumatic brain injury/trauma. Patients received ketamine in 495 TIs (23.9%), which increased from 10% in 2014 to 41% in 2020 (p < 0.001). Ketamine use was associated with a coindication of respiratory failure, difficult airway history, and use of vagolytic agents, apneic oxygenation, and video laryngoscopy. Composite adverse outcomes were reported in 289 (13.9%) Tis and were more common in the ketamine group (17.0% vs. 13.0%, p = 0.026). After adjusting for location, patient age and codiagnoses, the presence of respiratory failure and shock, difficult airway history, provider demographics, intubating device, and the use of apneic oxygenation, vagolytic agents, and neuromuscular blockade, ketamine use was not significantly associated with increased composite adverse outcomes (adjusted odds ratio 1.34, 95% confidence interval CI 0.99-1.81, p = 0.057). This paucity of association remained even when only neurotrauma intubations were considered (10.6% vs. 7.7%, p = 0.528).
CONCLUSIONS
CONCLUSIONS
This retrospective cohort study did not demonstrate an association between procedural ketamine use and increased risk of peri-intubation hypoxemia and hemodynamic instability in patients intubated for neurological indications.
Identifiants
pubmed: 37160847
doi: 10.1007/s12028-023-01734-0
pii: 10.1007/s12028-023-01734-0
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Agency for Healthcare Research and Quality
ID : R18HS022464
Organisme : Agency for Healthcare Research and Quality
ID : R18HS024511
Organisme : Agency for Healthcare Research and Quality
ID : R18HS024511
Organisme : Agency for Healthcare Research and Quality
ID : R18HS024511
Organisme : Agency for Healthcare Research and Quality
ID : R18HS024511
Organisme : Children's Hospital of Philadelphia
ID : Endowed Chair
Organisme : Children's Hospital of Philadelphia
ID : Critical Care Medicine
Informations de copyright
© 2023. Springer Science+Business Media, LLC, part of Springer Nature and Neurocritical Care Society.
Références
Shiima Y, Berg RA, Bogner HR, et al. Cardiac arrests associated with tracheal intubations in PICUs: a multicenter cohort study. Crit Care Med. 2016;44(9):1675–82. https://doi.org/10.1097/CCM.0000000000001741 .
doi: 10.1097/CCM.0000000000001741
pubmed: 27071070
Sanders RC, Giuliano JS, Sullivan JE, et al. Level of trainee and tracheal intubation outcomes. Pediatrics. 2013;131(3):e821–8. https://doi.org/10.1542/peds.2012-2127 .
doi: 10.1542/peds.2012-2127
pubmed: 23400606
Nishisaki A, Ferry S, Colborn S, et al. Characterization of tracheal intubation process of care and safety outcomes in a tertiary pediatric intensive care unit. Pediatr Crit Care Med. 2012;13(1):e5–10. https://doi.org/10.1097/PCC.0b013e3181fe472d .
doi: 10.1097/PCC.0b013e3181fe472d
pubmed: 21057359
Nishisaki A, Turner DA, Brown CA, et al. A National Emergency Airway Registry for children: landscape of tracheal intubation in 15 PICUs. Crit Care Med. 2013;41(3):874–85. https://doi.org/10.1097/CCM.0b013e3182746736 .
doi: 10.1097/CCM.0b013e3182746736
pubmed: 23328260
Mistry RB, Nahata MC. Ketamine for conscious sedation in pediatric emergency care. Pharmacotherapy. 2005;25(8):1104–11. https://doi.org/10.1592/phco.2005.25.8.1104 .
doi: 10.1592/phco.2005.25.8.1104
pubmed: 16207101
White PF, Way WL, Trevor AJ. Ketamine—its pharmacology and therapeutic uses. Anesthesiology. 1982;56(2):119–36. https://doi.org/10.1097/00000542-198202000-00007 .
doi: 10.1097/00000542-198202000-00007
pubmed: 6892475
Ng KC, Ang SY. Sedation with ketamine for paediatric procedures in the emergency department—a review of 500 cases. Singapore Med J. 2002;43(6):300–4.
pubmed: 12380727
Green SM, Hummel CB, Wittlake WA, Rothrock SG, Hopkins GA, Garrett W. What is the optimal dose of intramuscular ketamine for pediatric sedation? Acad Emerg Med. 1999;6(1):21–6. https://doi.org/10.1111/j.1553-2712.1999.tb00089.x .
doi: 10.1111/j.1553-2712.1999.tb00089.x
pubmed: 9928972
Wyte SR, Shapiro HM, Turner P, Harris AB. Ketamine-induced intracranial hypertension. Anesthesiology. 1972;36(2):174–6. https://doi.org/10.1097/00000542-197202000-00021 .
doi: 10.1097/00000542-197202000-00021
pubmed: 5059108
Filanovsky Y, Miller P, Kao J. Myth: Ketamine should not be used as an induction agent for intubation in patients with head injury. CJEM. 2010;12(2):154–7. https://doi.org/10.1017/s1481803500012197 .
doi: 10.1017/s1481803500012197
pubmed: 20219164
Albanèse J, Arnaud S, Rey M, Thomachot L, Alliez B, Martin C. Ketamine decreases intracranial pressure and electroencephalographic activity in traumatic brain injury patients during propofol sedation. Anesthesiology. 1997;87(6):1328–34. https://doi.org/10.1097/00000542-199712000-00011 .
doi: 10.1097/00000542-199712000-00011
pubmed: 9416717
Bar-Joseph G, Guilburd Y, Tamir A, Guilburd JN. Effectiveness of ketamine in decreasing intracranial pressure in children with intracranial hypertension. J Neurosurg Pediatr. 2009;4(1):40–6. https://doi.org/10.3171/2009.1.PEDS08319 .
doi: 10.3171/2009.1.PEDS08319
pubmed: 19569909
Conway JA, Kharayat P, Sanders RC, et al. Ketamine use for tracheal intubation in critically ill children is associated with a lower occurrence of adverse hemodynamic events. Crit Care Med. 2020;48(6):e489–97. https://doi.org/10.1097/CCM.0000000000004314 .
doi: 10.1097/CCM.0000000000004314
pubmed: 32317603
Ishimaru T, Goto T, Takahashi J, et al. Association of ketamine use with lower risks of post-intubation hypotension in hemodynamically-unstable patients in the emergency department. Sci Rep. 2019;9(1):17230. https://doi.org/10.1038/s41598-019-53360-6 .
doi: 10.1038/s41598-019-53360-6
pubmed: 31754159
pmcid: 6872717
Green SM, Krauss B. Ketamine is a safe, effective, and appropriate technique for emergency department paediatric procedural sedation. Emerg Med J. 2004;21(3):271–2. https://doi.org/10.1136/emj.2004.015370 .
doi: 10.1136/emj.2004.015370
pubmed: 15107359
pmcid: 1726339
Tarquinio KM, Howell JD, Montgomery V, et al. Current medication practice and tracheal intubation safety outcomes from a prospective multicenter observational cohort study. Pediatr Crit Care Med. 2015;16(3):210–8. https://doi.org/10.1097/PCC.0000000000000319 .
doi: 10.1097/PCC.0000000000000319
pubmed: 25581629
Daigle CH, Fiadjoe JE, Laverriere EK, et al. Difficult bag-mask ventilation in critically ill children is independently associated with adverse events. Crit Care Med. 2020;48(9):e744–52. https://doi.org/10.1097/ccm.0000000000004425 .
doi: 10.1097/ccm.0000000000004425
pubmed: 32590390
Takeshita H, Okuda Y, Sari A. The effects of ketamine on cerebral circulation and metabolism in man. Anesthesiology. 1972;36(1):69–75. https://doi.org/10.1097/00000542-197201000-00013 .
doi: 10.1097/00000542-197201000-00013
pubmed: 5006989
Scherzer D, Leder M, Tobias JD. Pro-con debate: etomidate or ketamine for rapid sequence intubation in pediatric patients. J Pediatr Pharmacol Ther. 2012;17(2):142–9. https://doi.org/10.5863/1551-6776-17.2.142 .
doi: 10.5863/1551-6776-17.2.142
pubmed: 23118665
pmcid: 3470433
Green SM, Andolfatto G, Krauss BS. Ketamine and intracranial pressure: no contraindication except hydrocephalus. Ann Emerg Med. 2015;65(1):52–4. https://doi.org/10.1016/j.annemergmed.2014.08.025 .
doi: 10.1016/j.annemergmed.2014.08.025
pubmed: 25245275
Gibbs JM. The effect of intravenous ketamine on cerebrospinal fluid pressure. Br J Anaesth. 1972;44(12):1298–302. https://doi.org/10.1093/bja/44.12.1298 .
doi: 10.1093/bja/44.12.1298
pubmed: 4650346
Evans J, Rosen M, Weeks RD, Wise C. Ketamine in neurosurgical procedures. Lancet. 1971;1(7688):40–1. https://doi.org/10.1016/s0140-6736(71)80041-7 .
doi: 10.1016/s0140-6736(71)80041-7
pubmed: 4099342
Crumrine RS, Nulsen FE, Weiss MH. Alterations in ventricular fluid pressure during ketamine anesthesia in hydrocephalic children. Anesthesiology. 1975;42(6):758–61. https://doi.org/10.1097/00000542-197506000-00026 .
doi: 10.1097/00000542-197506000-00026
pubmed: 1169035
Gardner AE, Olson BE, Lichtiger M. Cerebrospinal-fluid pressure during dissociative anesthesia with ketamine. Anesthesiology. 1971;35(2):226–8. https://doi.org/10.1097/00000542-197108000-00029 .
doi: 10.1097/00000542-197108000-00029
pubmed: 5568142
Shaprio HM, Wyte SR, Harris AB. Ketamine anaesthesia in patients with intracranial pathology. Br J Anaesth. 1972;44(11):1200–4. https://doi.org/10.1093/bja/44.11.1200 .
doi: 10.1093/bja/44.11.1200
pubmed: 4647115
Tjaden RJ, Ethier R, Gilbert RG, Straja A. The use of CI-581 (Ketalar) for pediatric pneumoencephalography. J Can Assoc Radiol. 1969;20(3):155–6 ((In eng)).
pubmed: 5307614
Lockhart CH, Jenkins JJ. Ketamine-induced apnea in patients with increased intracranial pressure. Anesthesiology. 1972;37(1):92–3. https://doi.org/10.1097/00000542-197207000-00020 .
doi: 10.1097/00000542-197207000-00020
pubmed: 5050109
List WF, Crumrine RS, Cascorbi HF, Weiss MH. Increased cerebrospinal fluid pressure after ketamine. Anesthesiology. 1972;36(1):98–9. https://doi.org/10.1097/00000542-197201000-00023 .
doi: 10.1097/00000542-197201000-00023
pubmed: 5006995
Waxman K, Shoemaker WC, Lippmann M. Cardiovascular effects of anesthetic induction with ketamine. Anesth Analg. 1980;59(5):355–8 ((In eng)).
doi: 10.1213/00000539-198005000-00007
pubmed: 7189381
Mohr NM, Pape SG, Runde D, Kaji AH, Walls RM, Brown CA 3rd. Etomidate use is associated with less hypotension than ketamine for emergency department sepsis intubations: a NEAR cohort study. Acad Emerg Med. 2020;27(11):1140–9. https://doi.org/10.1111/acem.14070 .
doi: 10.1111/acem.14070
pubmed: 32602974
pmcid: 8711033
April MD, Arana A, Schauer SG, et al. Ketamine versus etomidate and peri-intubation hypotension: a national emergency airway registry study. Acad Emerg Med. 2020;27(11):1106–15. https://doi.org/10.1111/acem.14063 .
doi: 10.1111/acem.14063
pubmed: 32592205
Pollack MA, Fenati GM, Pennington TW, et al. The use of ketamine for air medical rapid sequence intubation was not associated with a decrease in hypotension or cardiopulmonary arrest. Air Med J. 2020;39(2):111–5. https://doi.org/10.1016/j.amj.2019.11.003 .
doi: 10.1016/j.amj.2019.11.003
pubmed: 32197687
Fouche PF, Meadley B, St Clair T, et al. The association of ketamine induction with blood pressure changes in paramedic rapid sequence intubation of out-of-hospital traumatic brain injury. Acad Emerg Med. 2021;28(10):1134–41. https://doi.org/10.1111/acem.14256 .
doi: 10.1111/acem.14256
pubmed: 33759253
Kochanek PM, Tasker RC, Carney N, et al. Guidelines for the Management of Pediatric Severe Traumatic Brain Injury, Third Edition: Update of the Brain Trauma Foundation Guidelines. Pediatr Crit Care Med. 2019;20(3):S1–82. https://doi.org/10.1097/pcc.0000000000001735 .
doi: 10.1097/pcc.0000000000001735
pubmed: 30829890
Lang SS, Kumar NK, Zhao C, et al. Invasive brain tissue oxygen and intracranial pressure (ICP) monitoring versus ICP-only monitoring in pediatric severe traumatic brain injury. J Neurosurg Pediatr. 2022. https://doi.org/10.3171/2022.4.Peds21568 .
doi: 10.3171/2022.4.Peds21568
pubmed: 35623367
Figaji AA, Zwane E, Thompson C, et al. Brain tissue oxygen tension monitoring in pediatric severe traumatic brain injury@ Part 1: Relationship with outcome. Childs Nerv Syst. 2009;25(10):1325–33. https://doi.org/10.1007/s00381-009-0822-x .
doi: 10.1007/s00381-009-0822-x
pubmed: 19214532
Narotam PK, Burjonrappa SC, Raynor SC, Rao M, Taylon C. Cerebral oxygenation in major pediatric trauma: its relevance to trauma severity and outcome. J Pediatr Surg. 2006;41(3):505–13. https://doi.org/10.1016/j.jpedsurg.2005.11.069 .
doi: 10.1016/j.jpedsurg.2005.11.069
pubmed: 16516625
Hudetz JA, Pagel PS. Neuroprotection by ketamine: a review of the experimental and clinical evidence. J Cardiothorac Vasc Anesth. 2010;24(1):131–42. https://doi.org/10.1053/j.jvca.2009.05.008 .
doi: 10.1053/j.jvca.2009.05.008
pubmed: 19640746
Carlson AP, Abbas M, Alunday RL, Qeadan F, Shuttleworth CW. Spreading depolarization in acute brain injury inhibited by ketamine: a prospective, randomized, multiple crossover trial. J Neurosurg. 2018. https://doi.org/10.3171/2017.12.Jns171665 .
doi: 10.3171/2017.12.Jns171665
pubmed: 30544340
pmcid: 6279620
Dong C, Anand KJ. Developmental neurotoxicity of ketamine in pediatric clinical use. Toxicol Lett. 2013;220(1):53–60. https://doi.org/10.1016/j.toxlet.2013.03.030 .
doi: 10.1016/j.toxlet.2013.03.030
pubmed: 23566897